Woman Survives Stage 4 Breast Cancer After Seeking Treatment Abroad
Lynette McHendry defied odds with aggressive cancer, brain metastases, and BRCA1 positivity.
Trust 64Craft 87Hype 15How this was reported ▾
Includes named sources, specific figures with origins, and dates, but lacks documents or multiple outlets.
How well corroborated and evidenced the reporting is. Higher is better.
Explains relevance, quotes affected individuals, provides specific details, and maintains clear narrative.
Context, balance and separation of fact from comment. Higher is better.
Headline matches story tone; no exaggerated language or clickbait.
How far presentation runs ahead of substance. Lower is better.
1 source assessed · methodology

Lynette McHendry has overcome a decade-long battle with aggressive breast cancer, including stage 4 diagnoses and spread to her brain. Initially diagnosed at 37 with triple negative breast cancer in one breast and inflammatory breast cancer in the other, she has now maintained No Evidence of Active Disease (NEAD) status since 2018.
Seeking Advanced Treatment
Dissatisfied with local treatment plans in Northern Ireland, Ms. McHendry sought a second opinion at The Royal Marsden Hospital in London. This led to genetic testing, which confirmed she was BRCA1 positive. The hospital recommended platinum chemotherapy and PARP inhibitors, treatments not readily available to her at home at the time. She stated that women across the UK were receiving treatments she had not been offered, indicating Northern Ireland was behind in its approach to her specific type of cancer.
Sunseeker Holiday Homes enters administration
The Hull-based manufacturer, founded in 2019, has appointed administrators, putting 76 jobs at risk.
Her personalised treatment plan, which included tailored platinum chemotherapy and coming off a drug unsuitable for her, made a significant difference. Ms. McHendry highlighted that in 2026, patients with her condition receive more targeted therapies than were available a decade prior.
Battling Metastatic Disease
Following her initial breast cancer treatment, the cancer spread to her brain. Ms. McHendry underwent two separate craniotomies (brain surgeries) and received targeted stereotactic radiotherapy for brain lesions. She also experienced sepsis and partial paralysis during this period. Despite these challenges, a scan in 2018 showed she had achieved NEAD status, a condition she has maintained.
Enfield Town Liveable Neighbourhood scheme paused pending review
Transport for London funding for next phase is on hold as council re-evaluates project elements.
Reflecting on her journey, Ms. McHendry expressed gratitude for surviving a stage 4 diagnosis when many others she knew did not. She is now an advocate for living with cancer and believes advancements in treatments and drugs will allow more women to live longer with the disease. Professor Stuart McIntosh, a professor of surgical oncology at Queen's University Belfast, noted that Northern Ireland's role in developing treatments and pioneering clinical trials, such as for PARP inhibitors, has led to more positive prognoses for women.
Questions this report answers
+What treatment did Lynette McHendry receive that wasn’t available in Northern Ireland?
Lynette McHendry received platinum chemotherapy and PARP inhibitors at The Royal Marsden Hospital in London. These treatments were not readily available in Northern Ireland at the time, which she believes contributed to her improved outcome compared to others in the UK.
+How did Lynette McHendry’s cancer spread and what treatments did she have for it?
Her cancer spread to her brain, requiring two craniotomies (brain surgeries) and targeted stereotactic radiotherapy for brain lesions. Despite these challenges, including sepsis and partial paralysis, she achieved No Evidence of Active Disease status in 2018 and has maintained it since.
+What does ‘No Evidence of Active Disease’ mean for Lynette McHendry?
'No Evidence of Active Disease' means there is currently no detectable cancer in her body. Lynette McHendry has maintained this status since 2018, indicating her treatment has been successful in keeping the cancer at bay for over five years.
Barnet Press News Desk
This article was written at the Barnet Press news desk from the reporting of the outlets listed below it. Drafting is done by a language model under human editorial supervision — there is no reporter behind this byline, and we would rather say so than invent one.
How stories are produced and scoredWho runs Barnet PressCorrections
Barnet conditions
Loading live conditions…